Henrique Sergio Moraes Coelho
Overview
Explore the profile of Henrique Sergio Moraes Coelho including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandes E, Mello F, Andrade R, Girao C, Cesar C, Pimentel L, et al.
Arq Bras Cir Dig
. 2024 Dec;
37:e1839.
PMID: 39630840
Background: Intrahepatic cholangiocarcinoma (iCCA) was considered a contraindication for liver transplantation. However, recent studies have shown that highly selected cases of patients with a good response to neoadjuvant therapy may...
2.
Chagas A, Leal C, Mello V, Barros F, Bittencourt P, Mattos A, et al.
Arq Gastroenterol
. 2023 May;
60(1):106-131.
PMID: 37194769
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2020 the updated recommendations for the diagnosis and treatment...
3.
Villela-Nogueira C, Ferraz M, Pessoa M, Souto F, Cancella Nabuco L, Coelho H, et al.
Ann Hepatol
. 2022 Oct;
28(1):100764.
PMID: 36182033
Introduction And Objectives: The Choosing Wisely (CW) initiative aims to improve daily practice supported by evidence concerning unnecessary medical tests, procedures, and treatments. This philosophy is essential in managing viral...
4.
de Souza M Fernandes E, Mello F, Pimentel L, Andrade R, Girao C, Cesar C, et al.
Updates Surg
. 2022 Feb;
74(1):81-86.
PMID: 35103918
The association of a bariatric operation during liver transplantation may benefit patients with liver failure and obesity and sleeve gastrectomy emerges as the procedure of choice. The aim of this...
5.
Cabral B, Ramos J, Silveira A, Dos Santos Nascimento E, Ferreira S, Coelho H, et al.
Int J Infect Dis
. 2021 Dec;
115:171-177.
PMID: 34902582
Background: Hepatitis C virus (HCV) is a global public health problem. Second-generation direct-acting antivirals targeting non-structural regions on the viral genome are the cornerstone for treatment of chronic infection. However,...
6.
Barros F, Fernandes E, Fiod N, Coelho H, Martins S
Rev Col Bras Cir
. 2020 Jun;
47:e20202480.
PMID: 32555967
Objective: Portomesenteric vein thrombosis (PMVT) is a potentially severe complication that can occur after bariatric surgery. PMVT has gained importance because of the increasing number of bariatric surgeries being performed....
7.
Lobato C, Codes L, Silva G, Souza A, Coelho H, Lucia Alves Pedroso M, et al.
Ann Hepatol
. 2019 Sep;
18(6):849-854.
PMID: 31537509
Introduction And Objectives: Direct antiviral agents (DAAs) including sofosbuvir (SOF), daclatasvir (DCV), simeprevir (SIM) and ombitasvir, paritaprevir and dasabuvir were introduced 2015 in Brazil for treatment of hepatitis C virus...
8.
Lima de Souza S, Vidal L, Ramos J, Cardoso C, Coelho H, Villela-Nogueira C, et al.
Biomed Res Int
. 2018 Jun;
2018:2931486.
PMID: 29888255
Genotype 1 of hepatitis C virus (HCV) is the most prevalent worldwide. Pegylated-interferon and ribavirin therapy is still used in the developing world but has less efficiency in this genotype....
9.
Callefi L, Villela-Nogueira C, de Barros Tenore S, Carnauba-Junior D, Coelho H, Pinto P, et al.
Clinics (Sao Paulo)
. 2017 Jun;
72(6):378-385.
PMID: 28658438
Objective:: To evaluate the effectiveness and safety of first-generation protease inhibitors for the treatment of genotype 1 hepatitis C virus-infected patients at Brazilian reference centers. Methods:: This multicenter cross-sectional study...
10.
Chindamo M, Boursier J, Luiz R, Fouchard-Hubert I, Pannain V, Araujo Neto J, et al.
World J Hepatol
. 2017 Mar;
9(6):310-317.
PMID: 28293380
Aim: To evaluate the performance of FibroMeter combined to the first generation tests aspartate aminotransferase-to-platelet ratio index (APRI) or Forns index to assess significant fibrosis in chronic hepatitis C (CHC)....